“The FTC Study on Barriers to Entry in the Pharmaceutical Marketplace”

June 10, 2003

NOTICE OF RESCHEDULED HEARING

The hearing scheduled by the Senate Committee on the Judiciary for Tuesday, April 29, 2003 on "The FTC Study on Barriers to Entry in the Pharmaceutical Marketplace," has been rescheduled for Tuesday, June 17, 2003 at 10:00 a.m. in Dirksen Room 226 .

By order of the Chairman

------

Witness List

Hearing Before the Committee on the Judiciary
United States Senate
on
"Legislative and Regulatory Responses to the
FTC Study on Barriers to Entry in the
Pharmaceutical Marketplace"

Tuesday, June 17, 2003
10:00 a.m., 226 Dirksen Senate Office Building

Panel I

The Honorable Timothy J. Muris, Esq.
Chairman
Federal Trade Commission
Washington, D. C.

Mr. Dan Troy, Esq.
Chief Counsel for Food and Drugs
Food and Drug Administration
Rockville, MD

Mr. Sheldon T. Bradshaw, Esq.
Deputy Assistant Attorney General, Office of Legal Counsel
Department of Justice
Washington, D.C.

Panel 2

The Honorable Howard M. Metzenbaum, Esq.
Former United States Senator [D-OH]
Chairman
Consumer Federation of America
Washington, D.C.

Ms. Kathleen Jaeger, Esq.
President and CEO
Generic Pharmaceutical Association
Washington, D.C.

Mr. Bruce Kuhlik, Esq.
General Counsel
Pharmaceutical Research and Manufacturers of America
Washington, D.C.